V. Pingault et al., The SOX10 transcription factor: evaluation as a candidate gene for centraland peripheral hereditary myelin disorders, J NEUROL, 248(6), 2001, pp. 496-499
The SOX1O transcription factor is involved in development of neural crest d
erivatives and fate determination in glial cells. SOX10 mutations have been
found in patients with intestinal aganglionosis and depigmentation with de
afness (Waardenburg-Hirschsprung). Associated neurological signs have been
reported in some cases, including a patient exhibiting a central and periph
eral myelin deficiency. Therefore, we screened for SOX10 mutations in a lar
ge cohort of patients with peripheral and central myelin disorders. 56 were
affected by classical demyelinating Charcot-Marie-Tooth disease without id
entified mutations in the genes encoding PNS myelin proteins (PMP22, PO), c
onnexin 32 and the zinc-finger transcription factor, EGR2. 88 patients with
undetermined leukodystrophy were selected from a large European prospectiv
e study. Associated clinical, magnetic resonance imaging and electrophysiol
ogical signs were consistent with a defect in CNS myelination in 83 and wit
h an active degeneration of the CNS myelin in 5. No abnormalities in the pr
oteolipid protein gene (PLP) were found. The absence of SOX10 mutation in t
his large cohort of patients suggests that this gene is not frequently invo
lved in peripheral or central inherited myelin disorders.